Hansa Biopharma AB (HNSBF)
2.91
0.00 (0.00%)
USD |
OTCM |
Dec 15, 16:00
Hansa Biopharma EPS Diluted (Quarterly): -0.1838 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orexo AB | -- |
| Vivesto AB | -0.0042 |
| BioInvent International AB | -0.2063 |
| BioArctic AB | -0.103 |
| Camurus AB | 0.3356 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.58M |
| Revenue (Quarterly) | 3.237M |
| Total Expenses (Quarterly) | 18.81M |
| Enterprise Value | 361.63M |
| Gross Profit Margin (Quarterly) | 34.72% |
| Profit Margin (Quarterly) | -481.3% |
| Earnings Yield | -30.06% |
| Normalized Earnings Yield | -27.97 |